These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6198863)

  • 21. [Effect of hydroxyethyl starch, oxypolygelatin and human albumin on the phagocytic function of the reticuloendothelial system in healthy subjects].
    Lenz G; Hempel V; Junger H; Werle H; Buckenmaier P
    Anaesthesist; 1986 Jul; 35(7):423-8. PubMed ID: 2428269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass.
    Sade RM; Crawford FA; Dearing JP; Stroud M
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):35-8. PubMed ID: 6177973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The experimental study on hydroxyethyl starch--its partition in body water and effects on the body fluid dynamics--(author's transl)].
    Fukutome T
    Masui; 1977 Aug; 26(8):872-84. PubMed ID: 72172
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hyperamylasemia following infusion of hydroxyethyl starch with different molecular weight distributions].
    Gofferje H; Kozlik V
    Infusionsther Klin Ernahr; 1977 Jun; 4(3):141-4. PubMed ID: 70402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic changes following rapid infusion of a plasma substitute, hydroxyethyl starch. Evaluation of its effect on the circulating blood volume and application to left ventricular function test].
    Yamada T; Sakamoto T
    Masui; 1975 Sep; 24(9):891-8. PubMed ID: 53297
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.
    Haskell LP; Tannenberg AM
    N Y State J Med; 1988 Jul; 88(7):387-8. PubMed ID: 2457189
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of HES (hydroxyethyl starch) hemodilution on blood flow of various organs].
    Yoshikawa H; Yomamura H; Yamaguchi Y; Kosugi I; Okada K
    Masui; 1975 Jan; 24(1):12-7. PubMed ID: 47920
    [No Abstract]   [Full Text] [Related]  

  • 29. [Volume replacement and hemodilution with hydroxyethyl starch].
    Messmer K; Jesch F
    Infusionsther Klin Ernahr; 1978 Aug; 5(4):237-8. PubMed ID: 79556
    [No Abstract]   [Full Text] [Related]  

  • 30. Kidney damage by hydroxyethyl starch of lower molecular weight and substitution.
    Wiedermann CJ
    Eur J Anaesthesiol; 2009 Jan; 26(1):83-4. PubMed ID: 19122560
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fate of C-14 labeled hydroxyethyl starch in mice].
    Kościelak J; Gryszkiewicz A; Schier J; Góralski S
    Acta Haematol Pol; 1977; 8(4):303-7. PubMed ID: 75652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of hydroxyethyl starch in kidney failure].
    Köhler H; Kirch W; Vogt J; Höffler D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1676-8. PubMed ID: 77105
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma substitutes and coronary circulation. (1) Hydroxyethyl starch (HES)].
    Saito T; Sakata S; Okazaki K; Tomino T; Ohta N
    Masui; 1976 Jan; 25(1):29-34. PubMed ID: 56470
    [No Abstract]   [Full Text] [Related]  

  • 34. Biliary excretion of hydroxyethyl starch in man.
    Kalhorn TF; Yacobi A; Sum CY
    Biomed Mass Spectrom; 1984 Apr; 11(4):164-6. PubMed ID: 6203566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Heinz body formation and attachment to red cell membrane.
    Jacob HS
    Semin Hematol; 1970 Jul; 7(3):341-54. PubMed ID: 5425759
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
    Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of hydroxyethyl starch in cell separation].
    Bergmann H; Blaubut B; Necek S
    Wien Med Wochenschr; 1978 Jun; 128(12):335-6. PubMed ID: 78594
    [No Abstract]   [Full Text] [Related]  

  • 38. [Second effect on volume after a one-time infusion of hydroxyethyl starch].
    Köhler H; Kirch W; Pitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1756-8. PubMed ID: 77106
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of hydroxyethyl starch (6-HES)].
    Yamamoto E; Nakamura M; Mori J; Miyazaki C; Akamatsu S
    Masui; 1975 Jun; 24(6):570-3. PubMed ID: 51105
    [No Abstract]   [Full Text] [Related]  

  • 40. Contribution of Heinz bodies to alterations in red cell deformability.
    Weinstein RS; George ME; Steingart RH
    Toxicol Appl Pharmacol; 1975 Jun; 32(3):545-58. PubMed ID: 1154414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.